| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.4M | +9.0% |
| SG&A Expense | $8.1M | -15.9% |
| Net Income | -$10.4M | +37.0% |
| EPS (Basic) | -$0.33 | -158.9% |
| EPS (Diluted) | -$0.33 | -158.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $7.3M | +454.5% |
| Total Assets | $7.3M | +454.5% |
| Current Liabilities | $1.4M | +109.7% |
| Total Liabilities | $1.4M | +109.7% |
| Stockholders' Equity | $5.9M | +819.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.7M | +27.3% |
| Financing Cash Flow | $9.7M | +53.2% |